Royal Bank of Canada
ALXO icon

Royal Bank of Canada’s ALX Oncology ALXO Stock Holding History

Royal Bank of Canada’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4K Buy
1,879
+916
+95% +$1.75K ﹤0.01% 6466
2025
Q4 		$1K Sell
963
-140
-13% -$212 ﹤0.01% 6955
2025
Q3 		$2K Sell
1,103
-1,898
-63% -$1.64K ﹤0.01% 6856
2025
Q2 		$2K Buy
3,001
+998
+50% +$504 ﹤0.01% 6775
2025
Q1 		$1K Buy
2,003
+597
+42% +$717 ﹤0.01% 6621
2024
Q4 		$2K Sell
1,406
-6,964
-83% -$10.7K ﹤0.01% 6688
2024
Q3 		$15K Buy
8,370
+5,264
+169% +$19.6K ﹤0.01% 6194
2024
Q2 		$19K Buy
3,106
+2,506
+418% +$30.8K ﹤0.01% 6090
2024
Q1 		$7K Sell
600
-7,834
-93% -$110K ﹤0.01% 6309
2023
Q4 		$126K Buy
8,434
+4,754
+129% +$45.1K ﹤0.01% 5470
2023
Q3 		$17K Sell
3,680
-321
-8% -$1.74K ﹤0.01% 6228
2023
Q2 		$30K Buy
4,001
+2,776
+227% +$18.2K ﹤0.01% 6003
2023
Q1 		$5K Sell
1,225
-1,537
-56% -$11.6K ﹤0.01% 6549
2022
Q4 		$31K Buy
2,762
+2,501
+958% +$28.1K ﹤0.01% 6117
2022
Q3 		$2K Buy
261
+141
+118% +$1.64K ﹤0.01% 6978
2022
Q2 		$1K Sell
120
-969
-89% -$10.6K ﹤0.01% 7071
2022
Q1 		$18K Sell
1,089
-2,044
-65% -$34.9K ﹤0.01% 6650
2021
Q4 		$67K Buy
3,133
+3,025
+2,801% +$130K ﹤0.01% 6200
2021
Q3 		$8K Buy
108
+85
+370% +$5.67K ﹤0.01% 7026
2021
Q2 		$1K Sell
23
-1,324
-98% -$79.2K ﹤0.01% 7297
2021
Q1 		$99K Buy
1,347
+1,321
+5,081% +$104K ﹤0.01% 5469
2020
Q4 		$2K Buy
+26
New +$1.56K ﹤0.01% 6838

Other funds holding ALXO

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return

Royal Bank of Canada's ALXO Position: Q1 2026 in Review

Royal Bank of Canada increased its ALX Oncology (ALXO) stake by 95% in Q1 2026, buying an estimated $1.75K and bringing the position to 1,879 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #6466.

Royal Bank of Canada first reported a position in ALXO in Q4 2020 and has held it in 22 quarters since. The position peaked at $126K in Q4 2023. 69 funds tracked by Wall St. Rank hold ALXO as of Q1 2026.

  • Royal Bank of Canada held 1,879 shares of ALX Oncology worth $4K as of Q1 2026.
  • Royal Bank of Canada bought 916 ALX Oncology shares in Q1 2026, an estimated $1.75K.
  • ALX Oncology made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #6466 holding.
  • Royal Bank of Canada first reported a position in ALX Oncology in Q4 2020 and has held it in 22 quarters since.
  • Royal Bank of Canada's ALX Oncology position peaked at $126K in Q4 2023.
  • 69 funds tracked by Wall St. Rank held ALX Oncology as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.